LVMH Moet Hennessy - Louis Vuitton, Societe Europeenne

The company exceeded analysts' expectations for demand overall, but its most profitable division fell short of forecasts

Hermes accelerated sales growth while maintaining its status as the strongest in luxury. Why did the stock fall?

Alphabet Inc.

Netflix, Inc.

Meta Platforms, Inc.

Google is in talks with Anthropic to provide tens of billions of dollars worth of computing power, including access to Google's own TPU chips, to accelerate the development of its Claude line of language models. Samsung and Google showed off the Galaxy XR headset and Android XR operating system, laying the groundwork for future AI glasses with support for the Gemini assistant. About these and other topics - in our review of the key events for the morning of October 22.

Highlights for this morning: Google prepares Anthropic deal, Samsung and Meta expand horizons

General Motors Company

The automaker is strengthening its position in the U.S. domestic market and getting a boost from the Trump administration's policies

General Motors improves outlook, stock has best growth in five years. Is it worth buying?

MP Materials Corp.

High dependence on China and geopolitical risks pose a threat to global supply chains

Goldman saw risks to rare earth supply. Three stocks can protect

Jason Helfstein sees Google's parent company's securities as more promising in the short term

Oppenheimer compared the stocks of the two leaders of the AI world - Meta and Alphabet. Which one did he prefer?

Apple Inc.

Alcoa Corporation

In Japan, Sanae Takaichi won a key vote in parliament and will now become the country's first female prime minister. Apple shares hit an all-time high thanks to record sales of the iPhone 17. Australian rare earth producers soared after an $8.5 billion U.S.-Australia mineral deal, and Wall Street posted its best rally since June amid strong corporate earnings and expectations of easing trade tensions with China. On these and other topics - in the review of key events for the morning of October 21.

AstraZeneca PLC

Daiichi Sankyo Company, Limited

The Enhertu drug was found to be more effective than a drug from Swiss Roche

AstraZeneca's drug has produced positive results in the fight against breast cancer. What about the stock?

Tesla, Inc.

NVIDIA Corporation

Kering SA

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

Morning in New York: focus on geopolitics and corporate news

Europe is the only major region outside the U.S. where stocks are still trading at moderate multiples, analysts said

Deutsche Bank took a bullish stance on European equities. Why did it change its opinion?

Salesforce, Inc.

The company is betting on automation and new AI features, but analysts are still dubious about its prospects

Salesforce improved its revenue outlook. What's in store for its stock after a 25% drop?

Nestle S.A.

A new CEO is changing the Swiss giant's strategy, will the momentum be enough? 

Nestlé shares soared to their highest since 2008. The company will cut 6% of its workforce

The analyst expects the value of the securities to grow by 20%

Stocks